Docetaxel and cyclooxygenaze-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial
Author Department
Medicine
Document Type
Article, Peer-reviewed
Publication Date
5-1-2005
Recommended Citation
Nugent FW, Mertens WC, Graziano S, Levitan N, Collea R, Gujra A, Marshall J, McCann JC. Docetaxel and cyclooxygenaze-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial Lung cancer 2005 May;48(2):267-73.
COinS